Sustained Increases in IGFBP-7 May Be Related to Doxorubicin in Breast Cancer Patients is a research paper published in JACC CardioOncology (2021). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Ontario Genomics Institute
Grant: OGI-080
National Institutes of Health
Grant: R01Hl118018
National Institutes of Health
Grant: R21HL150723
National Institutes of Health
Grant: 1R21HL150723-01
Strategies in Cardiotoxicity Risk Reduction with Breast Cancer Therapy
National Institutes of Health
Grant: 5R01HL118018-02
Multimarker Risk Prediction in Cancer Therapy Cardiotoxicity
American College of Cardiology Foundation
AbbVie
Genome Canada
Amgen
Novartis Pharmaceuticals Corporation
Takeda Pharmaceuticals U.S.A.
Abbott Laboratories
Roche
Bayer Fund
Government of Canada
Fields of Study
Keywords